Comorbid amyloid-β pathology affects clinical and imaging features in VCD

[1]  Nick A. Weaver,et al.  Impact of white matter hyperintensity location on depressive symptoms in memory-clinic patients: a lesion–symptom mapping study , 2019, Journal of psychiatry & neuroscience : JPN.

[2]  A. Fagan,et al.  Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction , 2018, Nature Medicine.

[3]  Nick A. Weaver,et al.  IMPACT OF WHITE MATTER HYPERINTENSITY LOCATION ON DEPRESSIVE SYMPTOMS IN MEMORY CLINIC PATIENTS: A LESION-SYMPTOM MAPPING STUDY , 2018, Alzheimer's & Dementia.

[4]  J. Jansen,et al.  Blood–brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging , 2018, Brain Imaging and Behavior.

[5]  W. M. van der Flier,et al.  Amsterdam Dementia Cohort: Performing Research to Optimize Care , 2018, Journal of Alzheimer's disease : JAD.

[6]  W. M. van der Flier,et al.  Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results. , 2018, Clinical chemistry.

[7]  W. M. van der Flier,et al.  Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease , 2018, Neurology.

[8]  F. Barkhof,et al.  Bullseye's representation of cerebral white matter hyperintensities , 2017, Journal of neuroradiology. Journal de neuroradiologie.

[9]  Alan J. Thomas,et al.  Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease , 2017, Acta Neuropathologica.

[10]  J. Wardlaw,et al.  Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.

[11]  C. DeCarli,et al.  Impact of multiple pathologies on the threshold for clinically overt dementia , 2017, Acta Neuropathologica.

[12]  Nick A. Weaver,et al.  Lesion location and cognitive impact of cerebral small vessel disease. , 2017, Clinical science.

[13]  Sébastien Ourselin,et al.  A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis , 2016, NeuroImage.

[14]  V. Sossi,et al.  Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment , 2015, BMC Neurology.

[15]  Thomas Wisniewski,et al.  Clearance systems in the brain—implications for Alzheimer disease , 2015, Nature Reviews Neurology.

[16]  J. Ramirez,et al.  Unraveling the potential co-contributions of cerebral small vessel vasculopathy to the pathogenesis of Alzheimer’s dementia , 2015, Alzheimer's Research & Therapy.

[17]  Sébastien Ourselin,et al.  Template-Based Multimodal Joint Generative Model of Brain Data , 2015, IPMI.

[18]  Karen M Rodrigue,et al.  Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. , 2015, JAMA.

[19]  Jae Seung Kim,et al.  Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients , 2015, Alzheimer's & Dementia.

[20]  Sébastien Ourselin,et al.  Bayesian Model Selection for Pathological Neuroimaging Data Applied to White Matter Lesion Segmentation , 2015, IEEE Transactions on Medical Imaging.

[21]  K. Jellinger,et al.  Challenges of multimorbidity of the aging brain: a critical update , 2015, Journal of Neural Transmission.

[22]  S. Villeneuve,et al.  Are AD-Typical Regions the Convergence Point of Multiple Pathologies? , 2015, Front. Aging Neurosci..

[23]  Alan J. Thomas,et al.  Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes , 2015, Acta Neuropathologica.

[24]  C. Jack,et al.  Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly , 2015, Brain : a journal of neurology.

[25]  G. Kovacs,et al.  Prevalence of mixed pathologies in the aging brain , 2014, Alzheimer’s Research & Therapy.

[26]  J. Geiger,et al.  Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease. , 2014, Journal of neurology & neurophysiology.

[27]  W. M. van der Flier,et al.  Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. , 2014, JAMA Neurology.

[28]  Kenneth Rockwood,et al.  Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement , 2014, Alzheimer disease and associated disorders.

[29]  Miranka Wirth,et al.  Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions , 2014, Neurology.

[30]  Jae Seung Kim,et al.  Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment. , 2014, JAMA psychiatry.

[31]  M. Weiner,et al.  Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment , 2014, Neurobiology of Aging.

[32]  Thaddeus J. Haight,et al.  Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. , 2013, JAMA neurology.

[33]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[34]  K. Lunetta,et al.  APOE genotype and MRI markers of cerebrovascular disease , 2013, Neurology.

[35]  Cindee M. Madison,et al.  Cerebrovascular disease, beta-amyloid, and cognition in aging , 2012, Neurobiology of Aging.

[36]  Paula I. Moreira,et al.  Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation , 2012, Brain Research.

[37]  Carole Dufouil,et al.  Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging , 2012, Journal of Neurology.

[38]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[39]  C. Echávarri,et al.  Multiprotein Deposits in Neurodegenerative Disorders: Our Experience in the Tissue Brain Bank of Navarra , 2011, Anatomical record.

[40]  C. DeCarli,et al.  Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline , 2011, Alzheimer's & Dementia.

[41]  W. M. van der Flier,et al.  Incident lacunes influence cognitive decline , 2011, Neurology.

[42]  Sandra E. Black,et al.  Misclassified Tissue Volumes in Alzheimer Disease Patients With White Matter Hyperintensities: Importance of Lesion Segmentation Procedures for Volumetric Analysis , 2008, Stroke.

[43]  Niels D Prins,et al.  Cerebral small-vessel disease and decline in information processing speed, executive function and memory. , 2005, Brain : a journal of neurology.

[44]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[45]  Jerry L. Prince,et al.  An Eulerian PDE approach for computing tissue thickness , 2003, IEEE Transactions on Medical Imaging.

[46]  B. Reisberg,et al.  Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  John T. O'Brien,et al.  Vascular Cognitive Impairment , 2016, Continuum.

[48]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[49]  P. Scheltens,et al.  Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.

[50]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[51]  Amos D. Korczyn,et al.  Vascular dementia , 1993, Journal of the Neurological Sciences.

[52]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[53]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[54]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[55]  C. Nicholson,et al.  Clearance systems in the brain-implications for Alzheimer disease. , 2015, Nature reviews. Neurology.

[56]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.